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Available online 14 May 2016Ca2+-activated Cl− current (ICl(Ca)) mediated by TMEM16A and/or Bestrophin-3 may contribute to cardiac ar-
rhythmias. The true proﬁle of ICl(Ca) during an actual ventricular action potential (AP), however, is poorly
understood.
We aimed to study the proﬁle of ICl(Ca) systematically under physiological conditions (normal Ca2+ cycling and
AP voltage-clamp) as well as in conditions designed to change [Ca2+]i. The expression of TMEM16A and/or
Bestrophin-3 in canine and human left ventricular myocytes was examined. The possible spatial distribution of
these proteins and their co-localization with Cav1.2 was also studied.
The proﬁle of ICl(Ca), identiﬁed as a 9-anthracene carboxylic acid-sensitive current under AP voltage-clamp con-
ditions, contained an early fast outward and a late inward component, overlapping early and terminal repolari-
zations, respectively. Both components were moderately reduced by ryanodine, while fully abolished by BAPTA,
but not EGTA. [Ca2+]i was monitored using Fura-2-AM. Setting [Ca2+]i to the systolic level measured in the bulk
cytoplasm (1.1 μM) decreased ICl(Ca), while application of Bay K8644, isoproterenol, and faster stimulation rates
increased the amplitude of ICl(Ca). Ca2+-entry through L-type Ca2+ channels was essential for activation of
ICl(Ca). TMEM16A and Bestrophin-3 showed strong co-localization with one another and also with Cav1.2 chan-
nels, when assessed using immunolabeling and confocal microscopy in both canine myocytes and human ven-
tricular myocardium.
Activation of ICl(Ca) in canine ventricular cells requires Ca2+-entry through neighboring L-type Ca2+ channels and
is only augmented by SR Ca2+-release. Substantial activation of ICl(Ca) requires high Ca2+ concentration in the dy-
adic clefts which can be effectively buffered by BAPTA, but not EGTA.
© 2016 Elsevier Ltd. All rights reserved.Keywords:
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The role of anions in cardiac electrophysiology received far less at-
tention as physiological and pharmacological research has focused
mainly on cation channels [1] until the discovery of the cAMP-activated
Cl− current [2,3]. Anion currents are still less understood regarding their
molecular identity, physiological role and biophysical, pharmacological
properties [4,5]. Cl− channels are divided into four groups according to
their gating properties: ligand-gated channels, voltage-gated channels,
phosphorylation-regulated cystic ﬁbrosis transmembrane conductance
regulator channels and Ca2+-activated Cl− channels have been identi-
ﬁed so far [6].
Intracellular Ca2+ concentration ([Ca2+]i) and membrane potential
are changing dynamically and characteristically throughout the cardiac
cycle [7]. Accordingly, the actualmagnitudes of these variables delicate-
ly guide the Ca2+-activated Cl− current (ICl(Ca)) during the ventricular
action potential (AP). Moreover, the actual Ca2+ concentration in vari-
ous regions of the cell may also be very variable. Ca2+ concentration
in the dyadic cleft ([Ca2+]cleft) during systole is much higher than in
the bulk cytoplasm [8]. Increase in [Ca2+]i can dramatically shift the
voltage-dependence of ICl(Ca) towards more negative potentials [9].
Thus, the actual [Ca2+]cleft has a crucial role in setting the momentary
ICl(Ca) at any given membrane potential. The other peculiar property of
ICl(Ca), in contrast to other types of ion currents underlying the cardiac
AP, is that it canmediate both outward (Cl− inﬂux) and inward (Cl− ef-
ﬂux) currents because the reversal potential of Cl− lays between the
resting potential and the overshoot potential of the AP [10]. ICl(Ca) has
been characterized in the heart ﬁrst in the early 1990s [11] as a Ca2+-ac-
tivated but 4-aminopyridine insensitive component of the transient
outward current [12] contributing to the early (phase-1) repolarization
of cardiac cells [10].
Although a number of molecular candidates have been claimed to
mediate ICl(Ca), the molecular identity of the channel protein still re-
mains to be elucidated [6,10]. Recently a new family of anion channels,
the Bestrophins have been discovered and proposed to act as chloride
channels, or at least as their Ca2+-sensitive subunits [13]. This ﬁeld
was also highlighted by the identiﬁcation of TMEM16A (also known as
Anoctamin1 or Ano1) as another putative candidate for ICl(Ca) [14–16].
Moreover, TMEM16A expression was described in murine ventricle
and conﬁrmed to be responsible for ICl(Ca) in ventricular myocytes [17].
According to results obtained in rabbit myocytes, activation of ICl(Ca)
required Ca2+-induced Ca2+-release (CICR) from the sarcoplasmic re-
ticulum (SR) in addition to Ca2+-entry through the Ca2+ channels of
the sarcolemma [11,18,19]. Recent publications, however, raised the
possibility that activation of ICl(Ca) is mediated by a Ca2+ signal localized
at the sarcolemma [20,21]. Moreover, it has turned out that TMEM16A
channels are abundantly available in close proximity to IP3 receptors
in nociceptive neurons and to ryanodine receptors (RyRs) in smooth
muscle cells [21,22].
In the majority of previous studies ICl(Ca) was recorded under non
physiological conditions, i.e. when the Ca2+ homeostasis of the
myocytes was disturbed, the ionic composition was largely modiﬁed
and rectangular voltage pulses were applied. These studies have dem-
onstrated the existence of ICl(Ca) in many species, including rabbit [11,
19], sheep [23], pig [24], and dog [12], however, the role of ICl(Ca) during
the actual AP of the studied ventricular myocyte has not been investi-
gated so far.
ICl(Ca) can contribute to the development of cardiac arrhythmias.
ICl(Ca) may generate a component of the arrhythmogenic transient in-
ward current, leading to membrane depolarization (delayed
afterdepolarization, DAD) and triggered activity in Ca2+ overloaded
cells [17,25,26]. On the other hand, blocking the Cl− conductance by
9-anthracene carboxylic acid (9-AC) was shown to increase arrhythmia
incidence in canine ventricular cells [27].
Therefore the aims of our research were (1) to characterize ICl(Ca)
proﬁles under actual cardiac APs in canine ventricular cardiomyocytes,in a species with cardiac APs and ion currents most resembling to
those of human [28,29], (2) to study the Ca2+- and rate-dependence
of the current, (3) to conﬁrm Cl− as the charge carrier, (4) to examine
the role of transsarcolemmal Ca2+-entry and CICR in activation of
ICl(Ca) (5) to reveal the expression pattern of Bestrophin-3 and
TMEM16A and (6) to visualize their cellular appearance regarding co-
localization with each other as well as with pore forming subunit of L-
type Ca2+ channel (Cav1.2).
Action potential voltage-clamp (APVC) technique was used to re-
cord ICl(Ca) proﬁles as 9-AC-sensitive current (I9-AC) [30] under various
experimental conditions designed to alter intracellular calcium and
chloride concentrations. [Ca2+]i and cell shortening were also moni-
tored. Immunocytochemistry and confocal imagingwere used to detect
expression and co-localization of channel proteins in both canine left
ventricular myocytes and isolatedmyocytes andmulticellular ventricu-
lar preparations obtained from non-diseased human left ventricle. Our
results indicate that blockade of SR Ca2+-release may decrease, but
fails to eliminate the activation of ICl(Ca) in canine ventricular cells
conﬁrming the critical importance of transsarcolemmal Ca2+-entry
through L-type Ca2+ channels (LTCCs) in controlling ICl(Ca). TMEM16A
and Bestrophin-3 showed strong co-localization with one another and
also with Cav1.2 channels in both canine and human left ventricular
myocardium.
2. Methods
Detailed description of the applied methods including electrophysi-
ological protocols, composition of solutions, molecular biological re-
agents, etc. is provided in the Supplement.
Human hearts were obtained from organ donors whose non-dis-
eased hearts were explanted to obtain pulmonary and aortic valves for
transplant surgery. The investigations conformed to the principles of
the Declaration of Helsinki. Experimental protocols were approved by
the Ethical Review Board of the Medical Center of the University of Sze-
ged and by the Scientiﬁc and Research Ethical Committee of theMedical
Scientiﬁc Board at the Hungarian Ministry of Health (ETT-TUKEB; No.
51-57/1997 OEj and 4991-0/2010-1018EKU [339/PI/010]). After ex-
plantation, each heart was perfused with cardioplegic solution and
kept cold (4–6 °C) for 2–4 h prior to dissection. Cardiac samples were
ﬂash-frozen in liquid nitrogen and stored at−80 °C until use. In case
of studying cellular expression patterns of ion channel proteins single,
isolated left ventricular myocytes were used for immunocytochemistry
and confocal imaging.
All animal handling and laboratory procedures conform to the Guide
for the Care andUse of Laboratory Animals published by theUSNational
Institutes of Health (NIH publication no. 85-23, revised 1996), and to
our Institutional Animal Care and Use Committee approved protocols
(license no. 10/2011/DEMÁB). Chemicals and reagents were purchased
from Sigma-Aldrich Co. (St. Louis, MO, USA) if not speciﬁed otherwise.
Ryanodine was obtained from Cayman Chemical Co. (Ann Arbor, MI,
USA). All experiments except for molecular biological techniques were
applied at 37 °C and pH= 7.4.
Experimentswere performed in canine left ventricularmyocytes ob-
tained by enzymatic dispersion using the segment perfusion technique
[30]. Transmembrane ion currents were recorded using conventional
whole-cell voltage clamp and action potential voltage clamp (APVC)
techniques. In this latter case the own action potential of the myocyte,
recorded previously in current clamp mode in control (in the absence
of any drug in the perfusion solution), was played back as a command
signal to visualize the actually ﬂowing current proﬁles. ICl(Ca) was dis-
sected using 9-AC and presented as I9-AC. Single cell shortening was re-
corded by optical edge detection, while changes in intracellular free
Ca2+ concentrationwere assessed by Fura-2-AM (Molecular Probes, Eu-
gene, OR, USA). Electrical stimulationwas applied through the patch pi-
pette to simultaneously record the electrical and the Ca2+ signals from
the same cell except where otherwise stated. Immunolabeling for
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left ventricular myocytes and isolated myocytes and multicellular ven-
tricular preparations obtained from non-diseased human left ventricle,
while RyR and cytochrome c levels were studied only in canine cells.
Co-localization within pairs of the examined proteins was assessed by
off-line image analysis using Pearson correlation coefﬁcient.
All values are presented as arithmetic means ± SEM. Statistical sig-
niﬁcance of differences was evaluated using one-way ANOVA followed
by paired or unpaired Student's t-test as appropriate. Differences were
considered signiﬁcant when p was less than 0.05 and indicated with ei-
ther asterisks or + symbols.
3. Results
3.1. Ca2+- and voltage-dependent behavior of ICl(Ca) assessed by conven-
tional voltage-clamp
ICl(Ca) was deﬁned as a 9-AC-sensitive current (I9-AC), i.e. as a differ-
ence current obtained by measuring the current before and after appli-
cation of 0.5 mmol/L 9-AC during step depolarizations to a range of
voltages from−60 to +60 mV. According to our earlier results, ICl(Ca)
displayed a pronounced increase in its amplitude at membrane poten-
tials positive to−40mVwhennormal Ca2+ homeostasiswas preserved
(i.e. when the pipette solutionwas not buffered for Ca2+) [30]. ICl(Ca) ac-
tivated rapidly, but declined to a value close to zero within 20 ms (Fig.
1A). To conﬁrm its dependence on [Ca2+]i, the current was recordedFig. 1. Ca2+- and voltage-dependence of ICl(Ca) in canine ventricular myocytes. (A) Representati
ranging from−60 to +60 mV without applying a Ca2+ buffer in the pipette (voltage protocol
various intracellular Ca2+-buffering conditions: without Ca2+ buffer, 10 mmol/L EGTA or 10 m
without Ca2+ buffer in control (in Tyrode) and in the presence of 1 μmol/L nisoldipine (in
0.5 mmol/L 9-AC (ﬁlled circles). Symbols, columns and bars represent mean ± SEM values. As
(number of cells / number of hearts).in the presence of two chelators having different Ca2+ binding kinetics
and afﬁnity. Application of 10 mmol/L BAPTA in the pipette solution
without the addition of Ca2+ resulted in a great reduction of ICl(Ca) mak-
ing the current barely detectable at any test potential (0.07±0.01A/F at
+60 mV, Fig 1B). In contrast, application of 10 mmol/L EGTA in the pi-
pette – although reduced ICl(Ca) amplitude signiﬁcantly (from 2.44 ±
0.28 A/F to 1.49±0.27A/F at+60mV) – but failed to eliminate the cur-
rent. In addition, the voltage-dependence of ICl(Ca) in the presence and
absence of EGTA was essentially similar (Fig. 1B).
The Ca2+-dependence of ICl(Ca) was further studied by application of
a pipette solution designed to mimic the estimated peak systolic value
of [Ca2+]i (1.1 μmol/L free Ca2+). This was achieved by adding BAPTA
and appropriate amounts of Ca2+ to the pipette solution (see further de-
tails in the Supplement). The amplitude of ICl(Ca) was signiﬁcantly larger
when [Ca2+]i was set to 1.1 μmol/L (0.31± 0.06 A/F at+60mV in the 5
cells studied, not shown) comparing to values obtainedwith 10mmol/L
BAPTA, however, it wasmuch smaller than thatmeasuredwithout buff-
ering [Ca2+]i.
Applying 1 μmol/L nisoldipine, a selective inhibitor of L-type Ca2+
channels, further supported the Ca2+-dependent nature of ICl(Ca), since
both L-type Ca2+ current (ICa,L) and ICl(Ca) were eliminated by
nisoldipine (Fig. 1C). 9-AC had no inﬂuence on the amplitude of ICa,L in
the 5 studied cells (Fig. 1D).
These data are in line with the view that Ca2+-entry through L-type
Ca2+ channels (in addition to the concomitant Ca2+-release from the
SR) may be essential for the physiological activation of ICl(Ca).ve ICl(Ca) traces, determined as 0.5 mmol/L 9-AC-sensitive current (I9-AC), at test potentials
shown in the inset). (B) I9-AC amplitudes plotted as a function of the test potential under
mol/L BAPTA in the pipette solution). (C) Voltage-dependence of I9-AC and ICa,L measured
NISO). (D) ICa,L amplitude measured in the absence (open diamonds) and presence of
terisks denote signiﬁcant difference from control, n indicates the number of experiments
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recorded under APVC conditions
The inﬂuence of [Ca2+]i buffering (by EGTA or BAPTA) as well as the
preserved Ca2+-homeostasis (no calcium buffering) were further stud-
ied on AP conﬁguration and on the simultaneously recorded calcium
transients (CaTs). ICl(Ca) and ICa,L were studied using their speciﬁc
blockers (9-AC and nisoldipine, respectively) during the AP applyingFig. 2. Effect of various intracellular buffering conditions on the simultaneously recorded cardiac
pipettes containing no Ca2+ buffer (n = 4/2, where number of cells / number of hearts is give
(average of ten traces, measured with Fura-2-AM), diastolic [Ca2+]i, and CaT amplitude. (B
(APD90). (C) Representative INISO traces (1 μmol/L nisoldipine-sensitive current), INISO peak a
peak densities and total charges carried by outward (white columns) and inward currents (
inset. Columns and bars indicate mean ± SEM values, asterisks denote signiﬁcant differences f
of EGTA and BAPTA.sequential dissection of ionic currents under conditions of APVC. CaTs
were completely abolished when 10 mmol/L of a Ca2+ buffer (BAPTA
or EGTA) was added to the pipette solution, while characteristic CaTs
could be observed without these buffers (Fig. 2A). Importantly, these
CaTs recorded in whole-cell conﬁguration without using Ca2+ buffers
were not different from CaTs elicited with either ﬁeld stimulation or
by injecting current through sharp microelectrodes (data not shown).
Under these conditions intracellular Ca2+-handling must beAP, intracellular Ca2+ transient (CaT), INISO, and I9-AC. Cells were voltage-clamped through
n), 10 mmol/L EGTA (n = 9/4) or 10 mmol/L BAPTA (n = 6/3). (A) Representative CaTs
) Superimposed representative APs, phase-1 amplitudes, and action potential duration
nd total charge. (D) APVC recordings of ICl(Ca) (0.5 mmol/L 9-AC-sensitive current), I9-AC
black columns). The ﬁrst 35 ms of the representative traces is displayed enlarged in the
rom unbuffered condition, + symbols indicate signiﬁcant differences between the effects
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results, unloaded cell shortening was equally abolished by either
BAPTA or EGTA (not shown).
Using BAPTA-containing pipette solution resulted in a massive prolon-
gationofAPs accompaniedbyapronouncedpositive shift in theplateaupo-
tential. Phase-1 amplitude was decreased by both BAPTA and EGTA, this
effect was greater in the case of BAPTA than EGTA. In contrast to BAPTA,
EGTA failed to increase the duration of APs (Fig. 2B). Similarly, the proﬁle
of nisoldipine-sensitive current (INISO) was strongly different in the pres-
ence of the two Ca2+ buffers. BAPTA increased both the amplitude and in-
tegral of INISO signiﬁcantly, while EGTA had no such effect on these
parameters (Fig. 2C). On the other hand, INISO displayed a pronounced
early inactivation allowing a second inward peak to rise under Ca2+ buff-
er-free conditions in cells possessing a spike and dome type of AP. This sec-
ond peak disappeared in the presence of the calcium buffers (Fig. 2C).
9-AC dissected an early narrow outward current (Fig. 2D) having a
peak value of 1.62 ± 0.06 A/F which overlapped the phase-1 repolariza-
tion of the command AP (appearing 8.1 ± 0.4 ms after the peak of the
AP and 7.0 ± 0.9 ms before the end of phase-1 repolarization) (Supple-
mentary Fig. 1.). The outwardpeak always appeared later than the inward
peak of INISO by 6.4± 0.5mswhen studied with Sequential Dissection on
the same cells using 9-AC followed by nisoldipine (Supplementary Fig. 1).
This outward peak of I9-AC was followed by a smaller late inward current
reaching its maximum (−0.16 ± 0.02 A/F) towards the end of the AP.
BAPTA reduced signiﬁcantly both the outward aswell as the inward com-
ponents of I9-AC - the outward current peak decreased nearly to zero (see
data in Supplementary Table 1). The effect of EGTA on the early outward
current peak was smaller (1.17 ± 0.09 A/F, p less than 0.05) . These
changes in current amplitudes were also reﬂected by similar alterations
of current integrals (Fig. 2D). In summary, CaTs were completely
eliminated by both Ca2+ buffers, while BAPTA but not EGTA abolished
ICl(Ca) - probably due to a more effective buffering of [Ca2+]cleft.3.3. Effect of changes in [Cl−]i on the proﬁle of ICl(Ca) measured with APVC
In theAPVCexperiments described above, intracellular Cl− concentra-
tion ([Cl−]i) was set to 47 mmol/L, yielding a Cl− reversal potential of
−32 mV. In this case, without applying any Ca2+ buffer, I9-AC
displayed initially an early outward component which was followed by
a late inward component having peak densities of 1.62 ± 0.08 A/F and
−0.16 ± 0.03 A/F, respectively, in the 15 cells studied (Fig. 3C and
Supplementary Table 1). To test and reinforce the charge carrier, the con-
centrationof Cl− in thepipette solutionwas lowered to 27mmol/L (by re-
placing Cl− with equimolar aspartate) setting the new Cl− reversal
potential to−47mV. This reduction of [Cl−]i resulted in an enhancement
of the amplitude and integral of the early outward component, while the
late inward componentwas practically eliminated (Fig. 3G, H and Supple-
mentary Table 1). Plotting the phase-plane trajectories of I9-AC revealed
that regardless of the actual magnitude of [Cl−]i the outward current
was the largest within a narrow voltage-range corresponding to phase-
1 repolarization of the AP (Fig. 3E, F). These data are considered as further
supporting evidence that ICl(Ca) was indeed mediated by Cl−.3.4. Frequency-dependence of ICl(Ca) during physiological action potentials
I9-AC proﬁles were tested at two different steady-state pacing rates
under APVC conditions. As reported earlier [30], APD90 was increased
by 9-AC in a reverse-rate dependent manner (Fig. 4A, B). According to
the expectations, both systolic and diastolic [Ca2+]i were higher when
the preparations were stimulated at 2 Hz than at 1 Hz (Fig. 4C). In line
with the larger CaT, the density of I9-AC aswell as the total charge carried
by the outward component of the current signiﬁcantly increased when
stimulatory frequency was increased from 1 Hz to 2 Hz (Fig. 4D-F and
Supplementary Table 1).3.5. ICl(Ca) is increased by enhancement of ICa,L
As demonstrated by the experiments displayed in Fig. 1C and Fig. 2,
ICa,L seems to play a critical role in the activation of ICl(Ca). In the next ex-
periments ICa,L was enhanced by two different mechanisms. First a pro-
tein kinase A-dependent phosphorylation of the channel protein
(Cav1.2) was induced by the β-adrenergic agonist isoproterenol (ISO)
applied in a concentration of 10 nmol/L (Fig. 5) [31]. In another set of ex-
periments direct pharmacological stimulation of ICa,L was achieved by
20 nmol/L of Bay K8644 (Fig. 5) [32]. As it was conﬁrmed with the re-
cording of CaTs, both interventions resulted in an increased systolic cal-
cium concentration, although ISO was more potent in this regard (Fig.
5A, B). ISO acted similarly to Bay K8644: the plateau potential was in-
creased and phase-1 amplitude was reduced by both interventions
(Fig. 5C, D). In contrast, opposite effects were observed on the duration
of the AP, since AP was shortened by ISO while lengthened by Bay
K8644. This can be attributed to the enhancement of the slow delayed
rectiﬁer K+ current (IKs) by ISO [33]. IKs is not activated by Bay K8644
but ICa,L is expected to be increased by both 10 nmol/L ISO and
20 nmol/L Bay K8644. ICl(Ca) was dissected by 0.5 mmol/L 9-AC using
the AP recorded in Tyrode solution as the command signal. Both inward
and outward peaks of I9-AC were signiﬁcantly larger after pretreatment
with either 10 nmol/L isoproterenol or 20 nmol/L Bay K8644 as com-
pared to untreated controls (Fig. 5G). In addition, its proﬁle, its ampli-
tude and the total charge carried by I9-AC were similar after these
pharmacological interventions, irrespective of the way of ICa,L enhance-
ment (Fig. 5E–H). Enhancement of ICa,L led to a 2-fold increase in both
the outward and the inward components of I9-AC (Supplementary
Table 1). These results support the view that Ca2+-entry through the
L-type calcium channels is critically important in the activation of ICl(Ca).
3.6. Blockade of SR Ca2+-release by ryanodine fails to abolish ICl(Ca)
Contribution of CICR from the SR to the activation of ICl(Ca) was also
examined. Superfusion of the cells with 10 μmol/L ryanodine for
15 min greatly reduced both CaT and cell shortening (Fig. 6A).
Ryanodine exposure also resulted in the elevation of the early plateau
phase of AP (Fig. 6B, C). However, 0.5 mmol/L 9-AC applied in the pres-
ence of ryanodine caused a further reduction of phase-1 amplitude (Fig.
6B, C). Dissection of the corresponding ionic current by 9-AC under
APVC conditions using the AP recorded in Tyrode solution as the com-
mand signal demonstrated a clear-cut ICl(Ca) in the presence of
ryanodine, having its usual proﬁle, although its amplitude was signiﬁ-
cantly smaller than that measured under control conditions (Fig. 6D,
E, F, and Supplementary Table 1). Taken together, these data give strong
support to our hypothesis stating that CICR is not essential for, but con-
tributes to the activation of ICl(Ca) which is rather inﬂuenced by
transsarcolemmal Ca2+ entry.
3.7. Co-expression of TMEM16A, Bestrophin-3 and Cav1.2 in the t-tubules of
canine left ventricular cells
The expression pattern of potential channel protein candidates of
ICl(Ca) has been studied using immunocytochemistry and confocal mi-
croscopy. Cav1.2, the pore forming subunit of ICa,L, was also assessed.
The speciﬁcity of the applied antibodies was tested by omitting the pri-
mary antibodies during the incubation procedure and also by Western
blotting and immunocytochemistry (Supplementary Fig. 2). According
to expectations, Cav1.2 protein expression was most abundant in the
t-tubules (Fig. 7A and Supplementary Fig. 3A). Importantly, strong co-
localization was found between Cav1.2 and Bestrophin-3 indicated by
the 0.74 ± 0.03 value of the Pearson correlation coefﬁcient (PCC) ob-
tained in 8 cells prepared from 2 animals. TMEM16A showed a similar
expression pattern and strong co-localization with Bestrophin-3 (Fig.
7B and Supplementary Fig. 3B) with a PCC of 0.74 ± 0.06 (n= 8/2).
Fig. 3. Inﬂuence of [Cl−]i on ICl(Ca) proﬁle during self AP voltage-clamp recordings. The pipette solution contained either 47mmol/L (A, C, E) or 27mmol/L Cl− (B, D, F). Representative APs
(A, B) and the corresponding APVC recordings of I9-AC (C, D) are displayed. Panels E and F show phase-plane trajectories generated by plotting I9-AC amplitudes against the corresponding
values of membrane potential. Arrows indicate the temporal sequence. I9-AC peak densities (G) and total charges (H) estimated for outward (white columns) and inward currents (black
columns). Columns and bars indicate mean ± SEM values, asterisks denote signiﬁcant differences from data obtained with 47mmol/L Cl− containing pipettes. n indicates the number of
experiments where number of cells / number of hearts is given.
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canine cardiomyocytes
To exclude the possibility of an accidental co-expression and/or co-
localization, the expression of channel protein candidates of ICl(Ca) was
assessed together with other proteins. First the expression of cyto-
chrome c was tested with TMEM16A (Supplementary Fig. 4A). In spite
of the recognizable striated pattern of cytochrome c expression, theco-localization of cytochrome c and TMEM16A is unlikely as themerged
image did not show strong overlap (PCC was 0.25 ± 0.03 in 7 cells
of 2 animals). Although the co-localization of Bestrophin-3 with
RyR was slightly stronger (PCC = 0.36 ± 0.05) in 3 cells of 3 ani-
mals (see Supplementary Fig. 4B), it was much weaker than with
Cav1.2. Similarly, the co-localization of TMEM16A with RyR was
not pronounced (PCC of 0.31 ± 0.01) in 3 cells of 1 animal (not
shown).
Fig. 4. Rate-dependence of ICl(Ca) under APVC conditions. Upper panels show representative APs in control and in 0.5 mmol/L 9-AC at 1 (A) and 2 Hz (B) stimulatory frequencies.
Representative Ca2+ transients (C) and I9-AC traces (D) recorded at these pacing rates. I9-AC peak densities (E) and total charges (F) measured during outward (white columns) and
inward currents (black columns). The ﬁrst 30 ms of the current traces is shown enlarged in the inset of panel D. Columns and bars indicate mean ± SEM values, asterisks denote
signiﬁcant differences from data obtained at 1 Hz. Number of experiments at both frequencies were 5 cells/3 hearts.
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lar tissues and isolated left ventricular cardiomyocytes obtained from non-
diseased human hearts
The expression pattern of TMEM16A and Bestrophin-3 has been
studied using immunohistochemistry and confocal microscopy. Cav1.2
protein expression showed a striated pattern suggesting abundant ex-
pression in the t-tubules (Fig. 8A and Supplementary Fig. 5A). Similarly
to the results obtained in isolated canine myocytes, strong co-localiza-
tion was found between Cav1.2 and Bestrophin-3 indicated by the
0.71 ± 0.02 value of PCC obtained in the 7 human cryosections studied.
TMEM16A showed a similar expression pattern and strong co-localiza-
tion with Bestrophin-3 (Supplementary Fig. 5B) with a PCC of 0.80 ±
0.01, n = 7). In case of isolated human cells even stronger co-localiza-
tion was detected than in case of tissue samples or canine cells. PCC
for Cav1.2 and Bestrophin-3 yielded a 0.84 ± 0.02 value obtained in 18
cells prepared from two non-diseased human hearts (Fig. 8A).TMEM16A showed a similar expression pattern and strong co-localiza-
tion with Bestrophin-3 with a PCC of 0.85 ± 0.02 (n = 5/2) (Fig. 8B).
4. Discussion
4.1. Properties of ICl(Ca)
The present study aimed to characterize ICl(Ca) in isolated canine
ventricular myocytes under physiological conditions. This included the
application of APVC allowing to record the current during the physio-
logical AP waveform [34] and using pipette solution without buffering
of [Ca2+]i allowing to develop CaTswith normal kinetics. This is critical-
ly important in the case of a Ca2+-sensitive current, like ICl(Ca).
Although several studies described ICl(Ca) in various cardiac preparations
[11,12,19,23,24,35], the properties of ICl(Ca) under true APVC conditions (i.e.
when the current is studiedduring anAP recorded fromthe samemyocyte)
have not been analyzed. Furthermore, nonspeciﬁc blockers of the current,
Fig. 5. Stimulation of ICl(Ca) by isoproterenol and Bay K8644. Representative traces of Ca2+ transients (A, B) and APs (C, D) in control and in the presence of either 10 nmol/L isoproterenol
(ISO, A and C) or 20 nmol/L Bay K8644 (B and D). Representative ICl(Ca) records, dissected by 0.5 mmol/L 9-AC using the AP recorded in Tyrode solution as the command signal, in the
presence of ISO (E) and Bay K8644 (F). I9-AC peak densities (G) and total charges (H) estimated for outward (white columns) and inward currents (black columns). Columns and bars
indicate mean ± SEM values, asterisks denote signiﬁcant differences from control. n indicates the number of experiments where number of cells / number of hearts is given.
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4,4′-diisothiocyanostilbene-2,2′-disulfonic acid (DIDS)were applied for dis-
section of ICl(Ca) in the majority of these studies, which compounds are
known to block Na+ current as well [30]. In the only work performed to
study canine cardiac ICl(Ca) using APVC combined with perforated patch
clamp technique a “typical” AP was applied as the command signal and
nonspeciﬁc blockers were used to dissect ICl(Ca) [36].
Selectivity of the applied inhibitor, 9-AC is of major importance in
this study. It is critical not to alter ICa,L when a Ca2+-dependent current
such as ICl(Ca) is investigated. Fig. 1D indicates that 0.5 mmol/L 9-AC has
no inﬂuence on the amplitude of ICa,L. The major K+ currents, including
IKr, IKs and IK1 were also unaltered by the same dose of 9-AC as we have
shownpreviously [30]. It must be noted, however, that 9-ACwas shown
to also inhibit Cl− channels other than the Ca2+-activated ones. Volume
regulated Cl− current was unlikely to be involved in our experiments
because the osmolarity of the perfusion ﬂuid was carefully adjusted.
9-AC was shown to reduce ISO-induced cAMP-dependent Cl− currentas well in guinea pig ventricular myocytes [37], but these channels are
not expressed in canine [38] and human hearts [39].
ICl(Ca) was reported to be a rapidly activating and outwardly rectifying
transient current having a bell-shaped I‐V relation in the range of −40
and +100 mV when studied using rectangular voltage pulses [12]. Our
data show that ICl(Ca), deﬁned as 9-AC-sensitive current, possesses several
properties similar to those reported previously under conventional volt-
age-clamp conditions. (1) ICl(Ca) began to activate at−20mV, its amplitude
grew with increasing depolarizations having the largest peak around
+60 mV, and declined at more positive voltages (not shown, but see
Váczi et al. [30]). (2) Time-dependent decay of ICl(Ca) during these
depolarizing pulses, similarly to its activation, was rapid. (3) Activation of
ICl(Ca) required Ca2+ since it was abolished in the presence of nisoldipine
or 10mmol/L BAPTA (Fig. 1). (4) Changes of current amplitudewith partial
replacement of Cl− by non-permeant anion in the pipette were deducible
from the concomitant shift in the Cl− reversal potential. These similarities
were evident in spite of the different experimental conditions.
Fig. 6. Role of SR Ca2+-release in ICl(Ca) activation. (A) Effects of ryanodine on Ca2+ transient (top) and cell shortening (bottom) in a ﬁeld-stimulatedmyocyte. (B) Representative traces of
APs recorded in Tyrode solution (control), in the presence of 10 μmol/L ryanodine and following an additional superfusion with 0.5 mmol/L 9-AC. (C) Average phase-1 amplitudes and
APD90 values obtained under the above conditions in 4 myocytes of 3 animals. (D) Representative ICl(Ca) record measured in the presence of ryanodine with APVC. ICl(Ca) was dissected
by 0.5 mmol/L 9-AC (I9-AC) using the AP recorded in Tyrode solution as the command signal. E and F panels show average results on I9-AC peak densities and total charges ﬂowing
during the outward (white columns) and inward (black columns) current components. Columns and bars indicate mean ± SEM values, asterisks denote signiﬁcant differences from
control. n indicates the number of experiments where number of cells/number of hearts is given.
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usingAPVC,was composedof a fast, early outward and a late inward com-
ponent. The outward component showed a rapid activation as well as a
remarkable rapid decay in spite of the continuously elevated [Ca2+]i and
the existing large driving force for Cl− inﬂux. One possible explanation
for this rapid decay of ICl(Ca) might be the time dependent inactivation
of the channels mediating ICl(Ca). It had been shown, however, that in
the case of a constant [Ca2+]i ICl(Ca) showed a time-independent behavior
upon prolonged depolarization [12]making this option questionable. The
same study also suggested the existence of a low-afﬁnity Ca2+ binding
site evoking inactivation of ICl(Ca) [12]. The possible mechanism for
Ca2+-dependent inactivation (CDI) was studied in TMEM16A channels
expressed in HEK cells, where phosphorylation by a Ca2+-calmodulin de-
pendent protein kinase II was suggested [40]. This however is unlikely to
mediate CDI during the AP. A more likely explanation for the rapid decay
of ICl(Ca) may be the rapid and massive reduction of [Ca2+]cleft, a change
much faster and greater than observed with [Ca2+]i [41,42]. This is in
line with the co-localized arrangement of the Ca2+ and Cl− channelsallowing a direct guidance of ICl(Ca) by [Ca2+]cleft, which is strictly con-
trolled by the neighboring Ca2+ channels. Moreover, it was shown that
calmodulin can inactivate TMEM16A at [Ca2+] higher than 10 μmol/L at
least in HEK cells [43].
The late inward component in the proﬁle of ICl(Ca) appearing towards
the end of the AP also needs discussion. According to our hypothesis the
current is activated due to the combination of membrane potential and
an appropriate value of [Ca2+]cleft which it is still able to activate ICl(Ca)
but not too high to cause calmodulin dependent inactivation [43]. Dur-
ing terminal repolarization the membrane potential reduces below the
equilibrium potential of Cl− (−32 mV in our experiments except
when low [Cl−]i was used) therefore an inward current is generated
through open channels by the efﬂux of Cl−.
The source of the increase of [Ca2+]cleft during diastole can be the
spontaneous Ca2+-release through ryanodine receptors in a Ca2+-
overloaded cell [44,45]. The increase of [Ca2+]cleft can result in forma-
tion of arrhythmogenic delayed afterdepolarizations (DAD) by forward
mode operation of NCX and ICl(Ca) activation [26]. Activation of ICl(Ca) in
Fig. 7. Confocal images showing the expression pattern of Cav1.2, TMEM16A, and Bestrophin-3 in canine ventricular myocytes. (A) Representative cell showing the expression of Cav1.2,
Bestrophin-3, and nuclear staining in red, green, and blue, respectively, from left to right. The far right panel represents the overlay of the three images. (B) Representative cell showing the
expression of TMEM16A, Bestrophin-3, and nuclear staining in red, green, and blue, respectively, from left to right. The far right panel represents the overlay of the three images.
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tricular myocytes [46] was responsible for DAD formation highlighting
the pathophysiological signiﬁcance of ICl(Ca).
However, in a cellwithoutCa2+-overload increaseof [Ca2+]cleft to a level
where it can activate ICl(Ca) at the end of the AP is difﬁcult to explain. One
option is the ampliﬁcation of the window current of Ca2+ channels [47,
48] towards the end of the AP due to the growing driving force for Ca2+-in-
ﬂux. ICa,Lmediated Ca2+-inﬂux due to the reactivation of L-type Ca2+ chan-
nels during terminal repolarization was observed in guinea-pig ventricular
myocytes [49]. In some canine ventricular cells a similar late inward peak of
INISO measured in normal Ca2+ homeostasis (lack of exogenous Ca2+-buff-
ering) was also present (own unpublished observation).Another option is the release of Ca2+ frommyoﬁlaments at the end
of the AP [50] which is extruded via NCX and might also lead to the ac-
tivation of ICl(Ca). Experimental evidence exists showing this late activa-
tion of forwardmode NCX at the end of the AP in guinea-pig ventricular
cells [49] and also in canine cells [34]. Indeed, we have observed similar
timing of this inward INCX component and the ﬁnal inward ICl(Ca) record-
ed in the same cell (own unpublished observation).
Moreover, late Na+ current is largest towards the late plateau of the
APmeasured in APVC during intact Ca2+ homeostasis [45]. This Na+-in-
ﬂux slows down the previously mentioned Ca2+-extrusion via forward
modeNCX therefore delays the reduction of [Ca2+]cleft whichmight also
contribute to the activation of ICl(Ca).
Fig. 8. Confocal images showing the expression pattern of Cav1.2, TMEM16A, and Bestrophin-3 in left ventricular myocytes obtained from non-diseased human hearts. (A) Representative
cell showing the expression of Cav1.2, Bestrophin-3, and nuclear staining in red, green, and blue, respectively, from left to right. The far right panel represents the overlay of the three
images. (B) Representative cell showing the expression of TMEM16A, Bestrophin-3, and nuclear staining in red, green, and blue, respectively, from left to right. The far right panel
represents the overlay of the three images.
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reopening of Cl− channels at the end of the AP. During the majority of
the plateau phase of the AP TMEM16A can be inactive because high
[Ca2+] inactivates TMEM16A via calmodulin [43]. Upon the reduction
of [Ca2+]cleft Ca2+ can gradually dissociate from the low afﬁnity binding
site of calmodulin leading to the suspension of CDI of TMEM16A chan-
nels. In this scenario [Ca2+]cleft can be large enough to activate ICl(Ca)
but lower than that which causes calmodulin mediated CDI.
4.2. Ca2+-entry via ICa,L is essential for the activation of ICl(Ca), while Ca
2+-
release from SR only augments ICl(Ca)
Previous studies emphasized the principal role of SR Ca2+-release in
the activation of ICl(Ca) in rabbit atrial myocytes and Purkinje ﬁbers [18,
19]. In these studies long lasting (30–60 min) perfusion with ryanodinestrongly reduced the amplitude of CaTs eliminating contractions and
ICl(Ca). In contrast, we always observed large amplitude of ICl(Ca) in canine
myocytes in the continuous perfusion of 10 μmol/L ryanodine started
15 min prior to recording (Fig. 6). One might argue that 15 min pretreat-
ment is not enough to achieve the blockade of Ca2+-release from SR but
this is unlikely since both CaTs and cell shorteningwere largely abolished
within 8–10min of ryanodine perfusion (Fig. 6A). Further possible reason
for the observed differences in ryanodine-sensitivity of ICl(Ca)might be the
different animal model used or other differences in experimental condi-
tions. We applied canine ventricular cells in the present study in contrast
to others using atrialmyocytes andPurkinjeﬁbers of the rabbit [18,19], al-
though in a third study elimination of ICl(Ca) by ryanodinewas reported in
conventional voltage-clamp experiments conducted in canine ventricular
cells [12]. It is important to note that 9-AC was capable of decreasing
phase-1 amplitude even in the presence of ryanodine (Fig. 6B, C).
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presence of ryanodine (Fig. 6D) was very similar to that seen without
ryanodine (Fig. 3C) further conﬁrming that in our experimental setting
Ca2+-release from the SR is not an absolute requirement for the activation
of ICl(Ca).
In contrast to the limited efﬁcacy of ryanodine to eliminate ICl(Ca) in
our measurements, blockade of Ca2+-entry through LTCCs by
nisoldipine fully abolished ICl(Ca). Previous studies using calcium chan-
nel blockers, like cadmium, nisoldipine, and nicardipine described sim-
ilar results [11,51]. INISO peak always occurred earlier than the peak of
ICl(Ca) in our experiments (Supplementary Fig. 1) further conﬁrming
the essential role of Ca2+-entry through LTCCs in the physiological acti-
vation of ICl(Ca). It must be mentioned, however, that INISO is not exclu-
sively composed of ICa,L but it also contains all the electrogenic
processes which are inﬂuenced by Ca2+. The reason for it is that al-
though nisoldipine itself is highly selective for LTCC [34] but it also elim-
inates the major route of Ca2+-entry to the cell. As a consequence, the
trigger for CICR is reduced leading to a drop in both [Ca2+]cleft and
[Ca2+]i. Among those Ca2+-dependent processes which could be part
of INISO one can ﬁnd the current mediated by Na+/Ca2+ exchange
(INCX), Ca2+-dependent K+ channels, TRP channels and ICl(Ca) itself.
The contribution of ICl(Ca) is not an issue in our experiments because
nisoldipine was applied in the presence of 9-AC therefore ICl(Ca) has al-
ready been eliminated. Ca2+-dependent K+ channels and TRP channels
are unlikely to make a large contribution [52] to INISO which leaves INCX
as the other main component of INISO. INCX can be an outward current
leading to Ca2+-inﬂux at the beginning of the cardiac AP but this is lim-
ited to a fewmilliseconds [49,53]. Na+/Ca2+ exchanger generatesmain-
ly an inward current during the cardiac AP [49,54] which contributes to
a smaller or larger extent to INISO. According to Janvier et al. the two cur-
rents (INCX and ICa,L) have equal contribution to the inward current dur-
ing the plateau phase of ferret ventricular AP [54]. However, according
to results obtained using guinea pig ventricular cells under experimen-
tal conditions similar to our current study, the contribution of INCX to
INISO is much smaller especially during the early phase of AP plateau
(only about 25–30%) [49]. During the late plateau the contribution of
INCX and ICa,L to INISO becomes roughly equal [54]. In our experiments
we observed a substantial prolongation of the AP in the presence of
10 mmol/L BAPTA applied in the pipette solution (Fig. 2B), similarly to
what has been described in our earlier study also on canine cells in
the presence of 5 μmol/L BAPTA-AM [55]. This is in great contrast with
the study of Janvier et al. where the AP became shorter after the appli-
cation of 5 μmol/L BAPTA-AM [54]. This shortening was explained by
the reduction of INCX and therefore the smaller overall depolarizing
drive during the plateau phase in the presence of BAPTA-AM. The en-
hancement of ICa,L due to the lack of CDI of LTCC by strong [Ca2+]cleft
buffering can lead to the prolongation of the AP as seen in this study
(Fig. 2). This phenomenon, however, was not emphasized in the study
of Janvier et al. On the contrary, buffering Ca2+ increased ICa,L about
eight times compared to the physiological conditions according to
modeling results in the guinea pig cells [49]. It seems therefore that
the main effect of Ca2+-buffering in canine and guinea-pig cells is the
enhancement of ICa,L whereas in ferret ventricular cells the reduction
of INCX dominates explaining the opposite actions of Ca2+-buffering on
the duration of the AP. Our results therefore suggest that INCX is less
dominant in the dog than in ferret but it is more similar to that of guinea
pig in the maintenance of AP plateau. Another option is that in case of
canine cells the dominant effect of Ca2+-buffering is the increase of
ICa,L resulting in AP prolongation.
Our other experiments support the importance of Ca2+-entry
through LTCCs further. The amplitude of ICl(Ca) strongly increased
when ICa,L was enhanced either by ISO or Bay K8644 (Fig. 5). Both
drugs increases ICa,L but as Bay K8644 does not phosphorylate channel
proteins (unlike what is the case in the presence of ISO), direct interac-
tion with the Ca2+-activated Cl− channels can be excluded in this case.
However, both treatments increased ICa,L (not shown) and ICl(Ca)amplitudes to the same extent, while the concomitant elevations of
CaT amplitudes were not proportional (Fig. 5). In linewith this view, in-
creasing the stimulation rate from 1 to 2 Hz also increased ICl(Ca) proba-
bly due to the increased transsarcolemmal Ca2+ entry (Fig. 4).
Co-localization studies have revealed that LTCCs and RyRs are in close
proximity to one another within the dyadic cleft [56]. During excitation-
contraction coupling [Ca2+]cleft is believed to be much higher and has
faster kinetics than in the bulk cytoplasm [41,42]. However, measuring
[Ca2+]cleft directly is just becoming available [42,57]. According to our hy-
pothesis, ICl(Ca) is controlled locally, by [Ca2+]cleft, rather than bulk [Ca2+]i.
This approach is supported by the experiments aiming to set [Ca2+]i to
1.1 μmol/L (which corresponds topeak value of systolic [Ca2+]i) bydialyz-
ing cells with pipette solution containing 1.1 μmol/L of free Ca2+. In this
case, ICl(Ca) amplitude was much smaller, only 13% of the value obtained
without buffering [Ca2+]i. This is in a good agreement with the Ca2+-sen-
sitivity of ICl(Ca) determined in murine airway smooth muscle, where the
EC50was estimated to be 3.3 μmol/L but only 20–50 μmol/L [Ca2+]i result-
ed in full activation of the current [58]. Therefore, the signiﬁcantly larger
ICl(Ca) measured under physiological conditions, i.e. without buffering
[Ca2+]i, is probably due to the higher [Ca2+]cleft.
The different actions of EGTA and BAPTA on ICl(Ca) and ICa,L can also be
explained by the ability of Ca2+ chelators to differentially affect [Ca2+]i
and [Ca2+]cleft [59]. These agents suppress ICl(Ca) and CDI of ICa,L with dif-
ferent efﬁcacy. Although both buffers eliminated CaTs (Fig. 2A), only
BAPTA was effective to suppress CDI of ICa,L resulting in signiﬁcantly
higher INISO amplitude and total charge values (Fig. 2C) in addition to
the much longer AP (Fig. 2B). BAPTA fully eliminated ICl(Ca) during the
AP, while EGTA only decreased its amplitude and the total charge carried
by the current (Fig. 2D). These results are in a good agreement with the
conventional voltage-clamp observations (Fig. 1B). The reason for the dif-
ferent buffering efﬁcacy is that BAPTA has a 100 times faster binding rate
to Ca2+ than EGTA [59]. Similarly to the present study, effects of the two
buffers were compared on large-conductance Ca2+-activated K+ chan-
nels (BKCa) [60]. In line with our ﬁndings, namely that [Ca2+]cleft could
be buffered by the rapidly acting BAPTA, but not by EGTA, BKCa channels
could be activated by Ca2+ in the presence of EGTA,while the currentwas
fully abolished by BAPTA [60].
As mentioned previously, blockade of Ca2+-release from the SR
failed to fully abolish ICl(Ca), only some reduction of the current ampli-
tude was observed. It is rather difﬁcult, however, to judge the relative
contribution of Ca2+-entry through LTCC and Ca2+-release from SR to
the activation of ICl(Ca). One reason is that the CDI of ICa,L is known to
be reduced when Ca2+-release from SR is blocked (e.g. in the presence
of ryanodine). Therefore the relative contribution of LTCCs to ICl(Ca) acti-
vation is probably overestimated in the presence of ryanodine. Deter-
mining the precise contribution of these two mechanisms is further
complicated by the presence of several other Ca2+-dependent processes
involved in the ventricular electrical activity, including the Na+/Ca2+
exchanger, Ca2+-dependent K+ channels, and various Ca2+ pumps,
likely to be altered by changes in [Ca2+]i and even more by alterations
in [Ca2+]cleft. It would be important, therefore, tomeasure the [Ca2+]cleft
directly in the vicinity of the LTCC and Ca2+-activated Cl− channels. It
must be mentioned however that in this study we only examined the
source of Ca2+ that activates ICl(Ca) (via Ca2+-entry from the extracellu-
lar space or Ca2+ released from the SR) but we did not discriminate the
route of Ca2+-entry (via LTCC or reverse mode NCX). The contribution
of Ca2+-entry via NCX is unlikely to play amajor role if any in activating
ICl(Ca) (note the lack of outward current on INISO trace on the cell shown
on Supplementary Fig. 1) but can not be excluded.
4.3. Co-localization of Cav1.2 with TMEM16A and Bestrophin-3 proteins,
possible contributors of ICl(Ca)
In this study we tested the co-localization of Bestrophin-3 and/or
TMEM16A, the two likely candidates responsible for ICl(Ca) [13–16],
with Cav1.2 protein. The expression of Bestrophin-1 was demonstrated
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transfected to HEK cells, the resultant current recapitulated the charac-
teristics of ICl(Ca), including Ca2+-dependence, anion selectivity and sen-
sitivity to DIDS or niﬂumic acid [61]. The same group reported the
expression of Bestrophin-3 in murine and human heart (although only
at mRNA level in the latter) similarly to Bestrophin-1 [62]. Bestrophin-
3, when expressed in HEK cells, was activated by Ca2+ with the Kd of
175 nmol/L, and blocked by micromolar concentrations of DIDS and
niﬂumic acid [62]. The cellular expression of Bestrophin-3 in murine
ventricular cells showed a punctuated pattern which was strong in the
sarcolemma [62]. In our images obtained in canine ventricularmyocytes
the cellular expression of Bestrophin-3 showed striated pattern rather
than being punctuated. Bestrophin-3 expression in human samples
(left ventricular myocardium as well as isolated left ventricular cells),
similarly to that seen in canine cells, showed striated pattern.
Cardiac expression of TMEM16A has been described in murine ven-
tricle [17], but this is the ﬁrst report demonstrating it in canine and
human ventricular preparations. In both species a clear-cut striated pat-
ternwas observed. Importantly, the expression of Bestrophin-3 showed
strong co-localization with Cav1.2 channel protein (Fig. 7A and 8A) and
TMEM16A (Figs. 7B and 8B) making it very likely that Cav1.2 and
TMEM16A also co-localize with one another. In line with the results of
the present study Ca2+-activated Cl− channels localize close to RyR
and are controlled by local Ca2+ signals in airway smooth muscle [58].
On the contrary to our ﬁnding in rat dorsal root sensory neurons
TMEM16A channelswere reported to be activated by G protein-coupled
receptor induced Ca2+ release, but not by Ca2+-inﬂux through voltage-
gated Ca2+ channels [21]. As a mechanism behind this the tethering of
TMEM16A- and G protein-coupled receptor-containing, caveolin-1
enriched plasma membrane domains to juxtamembrane regions of
the endoplasmic reticulumwasmentioned. Here inositol 1,4,5-trisphos-
phate receptor 1 is the interacting partner of the carboxyl terminus and
ﬁrst intracellular loop of TMEM16A while voltage-gated Ca2+ channels
are located in other parts of theplasmamembrane [21]. On cardiacmus-
cle however caveolin-3 is associated to the same compartment with
Cav1.2 proteins amongmany other [63]. Moreover, in case of hippocam-
pal neurons TMEM16B was reported to appear in close proximity of
Ca2+ channels and NMDA receptors [64].
In addition, Bestrophins can associate with TMEM16A and contrib-
ute to the functional channel in vascular smooth muscle cells [65].
This possibility, however, is very difﬁcult to test since TMEM16Amodu-
lates Bestrophin expression [66]. Down-regulation of TMEM16A re-
duced the expression of Bestrophins, however, a reduced expression
of LTCCs has also been mentioned [66]. On the other hand, Bestrophins
were shown to form preferentially homomeric channels [67], similarly
to TMEM16A [68], which may question the ability of the two proteins
to form a single functional ion channel.
The striated pattern of TMEM16A, Bestrophin-3, and Cav1.2 expres-
sion is most likely due to the strong expression of these proteins in the
membranes of the t-tubules (Figs. 7 and 8). Similar images were pub-
lished in murine and human ventricular cardiomyocytes with Cav1.2 ex-
pression in the t-tubules [69]. The accidental co-localization of the
channel proteins due to technical factors of imaging is unlikely since the
co-localization of TMEM16Awith cytochrome cwasweak (Supplementa-
ry Fig. 4A). Similarly, less pronounced co-localization was seen between
Bestrophin-3 and RyR (Supplementary Fig. 4B) than between
Bestrophin-3 and TMEM16A/Cav1.2 (Figs. 7 and 8). The expression pat-
tern of RyR was very similar to that seen in rat ventricular myocytes
[70]. The co-localization of Cav1.2 with RyR and RyR with Cav1.2 was ap-
proximately 57 and 37%, respectively, in adult rat ventricular myocytes
[55].
4.4. Summary
The major ﬁnding of the present study was to show that Ca2+-entry
through LTCC is sufﬁcient for the activation of ICl(Ca) and does notrequire Ca2+-release from the SR through RyR. Our results demonstrate
the expression of Bestrophin-3 and TMEM16A in both canine and
human ventricular preparations for the ﬁrst time and the strong co-lo-
calization of Bestrophin-3 with TMEM16A and Cav1.2 protein. Elucida-
tion of the exact roles of TMEM16A and/or Bestrophin-3 in the
formation of ICl(Ca), however, requires further studies.
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